US Patent 9206251 Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
Patent 9206251 was granted and assigned to Alexion Pharmaceuticals, Inc. on December, 2015 by the United States Patent and Trademark Office.
Is a
Date Filed
July 1, 2015
0
Date of Patent
December 8, 2015
0
Patent Application Number
14789329
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9206251 Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
